Curatis Company
Founded in 2002 by experienced pharmaceutical industry executives, CURATIS is a privately owned specialty pharmaceutical company based in Switzerland. CURATIS is focused on the acquisition, development and commercialisation of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. CURATIS product portfolio included more than 25 medicines in therapy area's such as Oncology, Ultra Rare Diseases, Urology, Neurology, Antidotes and Hospital Products.